- Home
- ATOS vs STG Comparison
ATOS vs STG Comparison
Compare ATOS & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- STG
- Stock Information
- Founded
- ATOS 2009
- STG 2003
- Country
- ATOS United States
- STG China
- Employees
- ATOS N/A
- STG N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- STG Other Consumer Services
- Sector
- ATOS Health Care
- STG Real Estate
- Exchange
- ATOS Nasdaq
- STG Nasdaq
- Market Cap
- ATOS 107.2M
- STG 118.9M
- IPO Year
- ATOS 2012
- STG 2018
- Fundamental
- Price
- ATOS $0.84
- STG $8.82
- Analyst Decision
- ATOS Strong Buy
- STG
- Analyst Count
- ATOS 3
- STG 0
- Target Price
- ATOS $6.17
- STG N/A
- AVG Volume (30 Days)
- ATOS 483.0K
- STG 8.6K
- Earning Date
- ATOS 11-11-2025
- STG 08-14-2025
- Dividend Yield
- ATOS N/A
- STG N/A
- EPS Growth
- ATOS N/A
- STG N/A
- EPS
- ATOS N/A
- STG 3.59
- Revenue
- ATOS N/A
- STG $279,374,215.00
- Revenue This Year
- ATOS N/A
- STG N/A
- Revenue Next Year
- ATOS N/A
- STG N/A
- P/E Ratio
- ATOS N/A
- STG $2.45
- Revenue Growth
- ATOS N/A
- STG N/A
- 52 Week Low
- ATOS $0.55
- STG $4.28
- 52 Week High
- ATOS $1.66
- STG $15.00
- Technical
- Relative Strength Index (RSI)
- ATOS 60.84
- STG 46.35
- Support Level
- ATOS $0.81
- STG $8.11
- Resistance Level
- ATOS $0.80
- STG $8.95
- Average True Range (ATR)
- ATOS 0.03
- STG 0.56
- MACD
- ATOS 0.01
- STG -0.10
- Stochastic Oscillator
- ATOS 92.67
- STG 39.42
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.